Study shows rapamycin reverses myocardial defects in mouse model of LEOPARD syndrome
Links shared publicly online about this topic.
- 489total visits
Study shows rapamycin reverses myocardial defects in mouse model of LEOPARD syndrome
A new study showing that the mTOR inhibitor drug rapamycin can reverse cardiac muscle damage in a mouse model of LEOPARD syndrome not only identifies the first possible medical treatment for this rare condition, but also demonstrates the importance of targeted therapies in managing congenital heart disease.
View full resource at eurekalert.org
Tags: Heart, Heart Disease, Congenital Heart Defect, Muscle, Disease and Condition, Drug, Medical
Most Recently Shared on March 12, 2011 at 10:40 pm By:
Study shows rapamycin reverses myocardial defects in mouse model of LEOPARD syndrome: (Beth Israel Deaconess Med... http://bit.ly/gpzDMm
Rapamycin Reverses Myocardial Defects In Mouse Model Of Leopard Syndrome
medicalnewstoday.com — “Congenital heart diseases affect approximately one in 100 patients, making them the most common type of birth defect and the number-one cause of pediatric deaths. Now a new study showing” View full resource at medicalnewstoday.com
Most Recently Shared on February 22, 2011 at 3:05 pm By:
MNT Cardiovascular Health News
Rapamycin Reverses Myocardial Defects In Mouse Model Of Leopard Syndrome http://mnt.to/3Rr3 #cardiovascular
Advertisement
